Skip to main content
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis.
Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy.
International Consensus in Aiming to Define "Refractory ITP".
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
Incremental Eligibility Criteria for the BMT CTN 1507 Haploidentical Trial for Children with Sickle Cell Disease.
Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric Immune Thrombocytopenia.
Association of Busulfan Exposure and Outcomes after HCT for Patients with an Inborn Error of Immunity.
What's in a name: defining pediatric refractory ITP.
Effect of Rabbit ATG PK on Outcomes after TCR-αβ/CD19-depleted Pediatric Haploidentical HCT for Hematologic Malignancy.